ACE2 and COVID-19: An anthropological perspective

Area of Science:

• Virology
• Genetics
• Cardiology

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, has severe global health implications.
• The angiotensin-converting enzyme 2 (ACE2) receptor is crucial for SARS-CoV-2 entry into host cells.
• Comorbidities such as hypertension and type-2 diabetes are associated with severe COVID-19 outcomes.

Purpose of the Study:

• To review the relationship between SARS-CoV-2 infection, ACE2 expression, and cardiovascular complications.
• To explore the role of ACE2 gene polymorphism in SARS-CoV-2 infection susceptibility and severity.
• To investigate the association between ACE2 gene variations and the prevalence of hypertension and type-2 diabetes in COVID-19 patients.

Main Methods:

• Literature review of existing studies on SARS-CoV-2, ACE2, and related comorbidities.
• Analysis of data on ACE2 expression levels in different tissues and their correlation with viral entry.
• Examination of research on the impact of ACE2 gene polymorphisms across diverse populations.

Main Results:

• ACE2 expression levels and distribution may influence SARS-CoV-2 infectivity.
• Specific ACE2 gene polymorphisms are population-specific and may affect COVID-19 severity.
• A potential link exists between ACE2 variations, hypertension, type-2 diabetes, and adverse COVID-19 outcomes.

Conclusions:

• ACE2 plays a critical role in SARS-CoV-2 pathogenesis and disease progression.
• Population-specific screening of ACE2 polymorphisms could aid in assessing COVID-19 severity risk.
• Further research into the interplay of ACE2 genetics and comorbidities is warranted for personalized medicine approaches.